Impella percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: A retrospective analysis from a tertiary academic medical center.
Shayan Nabavi NouriWaqas MalickAmirali MasoumiJustin A FriedVeli K TopkaraMichael I BrenerYousif AhmadMegha PrasadLeRoy E RabbaniKoji TakedaDimitrios KarmpaliotisJeffrey W MosesMartin B LeonAjay J KirtaneArthur Reshad GaranPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Treatment with pLVAD for CS improved hemodynamic status but did not uniformly obviate MCS escalation. Mortality in CS remains high, though earlier device placement for appropriately selected patients may be beneficial.
Keyphrases
- left ventricular assist device
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- extracorporeal membrane oxygenation
- peritoneal dialysis
- ultrasound guided
- prognostic factors
- randomized controlled trial
- coronary artery disease
- open label
- minimally invasive
- patient reported outcomes
- replacement therapy
- smoking cessation
- double blind